Navigation Links
WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests
Date:10/9/2007

SALEM, N.H., Oct. 9 /PRNewswire/ -- The Wellion Linus Blood Glucose Monitoring System, powered by WaveSense technology for high accuracy testing, recently received certification by the Netherlands Organization for Applied Scientific Research TNO ("TNO"). TNO is an independent group founded in 1932 that thoroughly tests and inspects medical devices. The Wellion Linus Blood Glucose also carries the CE Marking.

"Receiving the TNO approval is a testament to the quality and accuracy of WaveSense products," said Dr. E. van Ballegooie, one of the leading physicians in the Belgium/Netherlands/Luxembourg region. "Roche and Abbott are the other major brands to receive the TNO approval; this clearly demonstrates that WaveSense is one of the leading technologies in the world."

In addition to market leading features such as having a fast test time, small sample size, and large backlit display, the Wellion Linus's main feature is its ability to provide high accuracy test results due to its WaveSense technology. For a list of the other blood glucose monitors that have received TNO approval, see: http://www.tnokeur.nl/.

"TNO is known throughout Europe for their high standards and its tests are often more rigorous than the requirements for the mandatory CE Marking. We are honored to place the prestigious TNO seal on our WaveSense products. TNO certification is a tremendous advantage since we are penetrating demanding markets, such as The Netherlands, where users prefer very rigorous accuracy standards for home blood glucose monitoring systems," said Werner Trenker, CEO of MedTrust, distributor of WaveSense products in Europe.

WaveSense technology is a suite of patented technologies that enable high accuracy glucose monitoring products. WaveSense employs Dynamic Electrochemistry to extract a spectrum of information inaccessible to traditional static electrochemistry methods. WaveSense technology aids in the detection of a wide range of variables that can distort a glucose reading, these variables can be corrected through advanced signal processing algorithms in the meter, thus leading to accurate readings.

"Accuracy is the most important feature of any glucose monitoring system. If people are checking their blood sugar regularly, they may as well get a reliable number. Getting wildly fluctuating readings is one of the most discouraging aspects of monitoring. WaveSense products help users by providing consistent, repeatable results that they trust," says John Walsh, PA, CDE, Diabetes Clinical Specialist at Advanced Metabolic Care + Research in Escondido, CA, and author of Pumping Insulin: Everything You Need For Success On A Smart Insulin Pump. "And being one of the few meters that has passed TNO standards really speaks to the performance and quality of the WaveSense Meter."

The Wellion Linus, powered by WaveSense technology, also holds the CE Mark and is commercially available in many countries throughout Europe. The Wellion Linus is marketed as the WaveSense KeyNote and the Liberty Meter in the United States, the iTest in Canada, and the GracePro in China.


'/>"/>
SOURCE AgaMatrix
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
4. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
5. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
8. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
Breaking Medicine Technology:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... human performance, is proud to announce that it has received 510(k) clearance from ... the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling ...
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... BC (PRWEB) , ... April 25, 2017 , ... The ... from Richmond, BC, who live with dental fear and require sedation to receive dental ... at ease during various procedures, from hygienic cleanings to oral surgery, at their ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as well ... society for this important science. , The Teratology Society is ...
(Date:4/25/2017)... Clara, CA (PRWEB) , ... April 25, 2017 ... ... announces the addition of predictive analytics to its patient care management module. Using ... compliance even before a patient has been initiated on continuous positive airway pressure ...
Breaking Medicine News(10 mins):